M1-NP1 Interfering-Peptide Inhibits Cancer Cell Proliferation and Migration by Targeting FOXM1

Forkhead box protein M1 (FOXM1) is a transcription factor frequently overexpressed in various human malignancies, driving cancer cell proliferation and invasion. Its critical role makes it a promising target for anti-cancer therapies. However, developing specific inhibitors remains a challenge, necessitating novel approaches to modulate its activity and overcome therapeutic resistance. This paper explores a new peptide-based strategy to target FOXM1 and its downstream effects on cancer progression.

Researchers employed yeast-two-hybrid (Y2H) screening to identify a novel FOXM1-targeting peptide, M1-NP1. The study then investigated the peptide's effects on cancer cell proliferation and migration. Specific cell lines, doses, or detailed experimental protocols were not explicitly detailed in the abstract, but the core mechanism involved M1-NP1 directly interfering with the activity of the transcription factor FOXM1 to achieve its anti-cancer effects.

The study successfully identified M1-NP1 as a novel peptide capable of targeting the transcription factor FOXM1. > M1-NP1 demonstrated a significant inhibitory effect on cancer cell proliferation. Furthermore, the peptide was found to effectively inhibit cancer cell migration. These observed effects were directly attributed to M1-NP1's ability to interfere with FOXM1 activity. The abstract did not provide specific quantitative data, such as percentages of inhibition, p-values, or fold-changes, regarding the observed effects on cell cycle or migration.